Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CRDLTSE:HLSTSE:LABSTSE:TGOD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRDLCardiol Therapeutics$1.10+2.8%$1.04$0.77▼$3.12$90.87M0.98362,805 shs198,500 shsHLSHLS TherapeuticsC$4.68+0.6%C$4.42C$3.00▼C$4.98C$104.12M1.0713,643 shs2,821 shsLABSMediPharm LabsC$0.08-6.3%C$0.09C$0.06▼C$0.12C$31.13M0.88345,797 shs26,759 shsTGODGreen Organic DutchmanC$0.00C$0.17▼C$0.65C$89.95MN/A2.66 million shs19.70 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRDLCardiol Therapeutics0.00%-0.90%+2.80%-8.33%-49.54%HLSHLS Therapeutics0.00%-2.50%+12.23%+12.23%+21.56%LABSMediPharm Labs0.00%-16.67%-16.67%+15.38%-6.25%TGODGreen Organic Dutchman0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCRDLCardiol Therapeutics1.5299 of 5 stars3.73.00.00.00.00.00.6HLSHLS Therapeutics0.5043 of 5 stars1.00.01.70.02.31.70.0LABSMediPharm LabsN/AN/AN/AN/AN/AN/AN/AN/ATGODGreen Organic DutchmanN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRDLCardiol Therapeutics 3.40Buy$8.67687.88% UpsideHLSHLS Therapeutics 2.00HoldC$4.50-3.85% DownsideLABSMediPharm Labs 0.00N/AN/AN/ATGODGreen Organic Dutchman 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest LABS, CRDL, HLS, and TGOD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/16/2025CRDLCardiol TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.004/7/2025CRDLCardiol TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.003/26/2025HLSHLS TherapeuticsStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHoldC$3.50 ➝ C$4.00(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRDLCardiol TherapeuticsN/AN/AN/AN/A$0.32 per shareN/AHLSHLS TherapeuticsC$40.13M2.59C$0.31 per share15.22C$2.51 per share1.86LABSMediPharm LabsC$39.42M0.79C$0.06 per share1.30C$0.11 per share0.68TGODGreen Organic DutchmanC$31.37M0.00N/A10.63C$0.26 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRDLCardiol Therapeutics-$20.84M-$0.34N/AN/AN/AN/A-194.40%-129.07%7/14/2025 (Estimated)HLSHLS Therapeutics-C$15.53M-C$1.00N/A∞N/A-38.70%-25.27%-2.89%N/ALABSMediPharm Labs-C$12.05M-C$0.03N/A∞N/A-30.56%-24.41%-7.17%N/ATGODGreen Organic DutchmanN/A-C$0.26N/AN/AN/AN/AN/AN/AN/ALatest LABS, CRDL, HLS, and TGOD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/31/2025Q4 2024CRDLCardiol Therapeutics-$0.08-$0.07+$0.01-$0.07N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRDLCardiol TherapeuticsN/AN/AN/AN/AN/AHLSHLS TherapeuticsC$0.204.27%N/AN/A N/ALABSMediPharm LabsN/AN/AN/AN/AN/ATGODGreen Organic DutchmanN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRDLCardiol Therapeutics0.012.492.49HLSHLS Therapeutics86.501.561.01LABSMediPharm Labs1.453.213.10TGODGreen Organic Dutchman16.771.280.50Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRDLCardiol Therapeutics12.49%HLSHLS Therapeutics65.20%LABSMediPharm Labs0.71%TGODGreen Organic DutchmanN/AInsider OwnershipCompanyInsider OwnershipCRDLCardiol Therapeutics5.25%HLSHLS Therapeutics0.37%LABSMediPharm Labs4.45%TGODGreen Organic DutchmanN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRDLCardiol Therapeutics2082.61 million78.27 millionNot OptionableHLSHLS Therapeutics9122.25 millionN/ANot OptionableLABSMediPharm Labs130415.00 millionN/ANot OptionableTGODGreen Organic Dutchman41529.14 millionN/ANot OptionableLABS, CRDL, HLS, and TGOD HeadlinesRecent News About These CompaniesAnne-Marie GreenApril 23, 2024 | cbsnews.comOrganic green smoothies for kidsMarch 31, 2024 | nzherald.co.nzNorris GreenFebruary 1, 2024 | liverpoolecho.co.ukGreen beans recipesDecember 22, 2023 | bbc.co.ukCannabis producer Bzam ‘dramatically reduces’ head count after TGOD mergerSeptember 19, 2023 | mjbizdaily.comBZAM Ltd. Reports First Quarter 2023 Financial Results; Achieves Record RevenuesMay 30, 2023 | benzinga.comBZAM cannabis stock keeps Speculative Buy rating with ClarusMay 2, 2023 | cantechletter.comBZAM is a double in Canadian cannabis, says ClarusMarch 30, 2023 | cantechletter.comThe Green Organic Dutchman Announces Effective Date of Name Change to BZAM Ltd. And New Appointment to its Board of DirectorsFebruary 21, 2023 | finance.yahoo.comCannabis company The Green Organic Dutchman Holdings changing name to BZAMJanuary 25, 2023 | ca.finance.yahoo.comThe Green Organic Dutchman Releases Escrowed Shares And Issues New SharesJanuary 23, 2023 | msn.comThe Green Organic Dutchman Holdings Ltd (TGOD-WR.CN)January 2, 2023 | finance.yahoo.comThe Green Organic Dutchman Closes $5M Public OfferingDecember 22, 2022 | msn.comThe Green Organic Dutchman Holdings Ltd. Announces Closing of Previously Announced Marketed Public Offering of UnitsDecember 22, 2022 | yahoo.comCannabis market is consolidating, says Raymond JamesOctober 25, 2022 | cantechletter.comThe Green Organic Dutchman Holdings Ltd.: The Green Organic Dutchman Enters Into a Definitive Agreement To Merge With BZAM CannabisOctober 20, 2022 | finanznachrichten.deThe Green Organic Dutchman signs deal to merge with BZAM CannabisOctober 19, 2022 | timescolonist.comCanadian companies Green Organic Dutchman, BZAM Cannabis to mergeOctober 19, 2022 | mjbizdaily.comThe Green Organic Dutchman Launches Four New Cannabis ProductsSeptember 21, 2022 | msn.comThe Green Organic Dutchman launches exciting new products Fall 2022 in British Columbia, Alberta & OntarioSeptember 21, 2022 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLABS, CRDL, HLS, and TGOD Company DescriptionsCardiol Therapeutics NASDAQ:CRDL$1.10 +0.03 (+2.80%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.12 +0.02 (+1.82%) As of 05/23/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.HLS Therapeutics TSE:HLSC$4.68 +0.03 (+0.65%) As of 05/23/2025 02:30 PM EasternHLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.MediPharm Labs TSE:LABSC$0.08 -0.01 (-6.25%) As of 05/23/2025 03:58 PM EasternMediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4. Its geographical segments are Canada and Australia.Green Organic Dutchman TSE:TGODThe Green Organic Dutchman Holdings Ltd., through its subsidiaries, produces and sells organic cannabis in Canada. It offers organic cannabis products, such as cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis to retailers or distributors, and federal licensed entities. The Green Organic Dutchman Holdings Ltd. was incorporated in 2016 and is headquartered in Mississauga, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Alphabet Stock Lags—But Waymo May Be Its Hidden Driver This Market Sell-Off Might Trigger a Value Rotation Into Pepsi Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
